Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor

Gut

Volumn 56, Issue 1, 2007, Pages 43-51

  Lippert, E ^a   Falk, W ^a   Bataille, F ^a   Kaehne, T ^b   Naumann, M ^b   Goeke, M ^c   Herfarfh, H ^a   Schoelmerich, J ^a   Rogler, G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; GALECTIN 3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STOMACH EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CACO-2 CELLS; CELL LINE; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; CULTURE MEDIA, CONDITIONED; DIVERTICULITIS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GALECTIN 3; HT29 CELLS; HUMANS; INTERLEUKIN-8; INTESTINAL DISEASES; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1;

EID: 33846024093     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.081646     Document Type: Article

References (46)

1. Gillitzer R, Goebeler M. Chemokines in cutaneous wound healing. J Leukoc Biol 2001;69:513-21.
2. Tranquillo RT, Murray JD. Mechanistic model of wound contraction. J Surg Res 1993;55:233-47.
3. Nedelec B, Ghahary A, Scott PG, et al. Control of wound contraction. Basic and clinical features. Hand Clin 2000;16:289- 302.
4. Rogler G, Gelbmann CM, Vogl D, et al. Differential activation of cytokine secretion in primary human colonic fibroblast/ myofibroblast cultures. Scand J Gastroenterol 2001;36:389-98.
5. Pang G, Couch L, Batey R, et al. GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysacchariae, IL-1 alpha and TNF-alpha. Clin Exp Immunol 1994;96:437-43.
6. Graham MF, Diegelmann RF, Elson CO, et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988;94:257-65.
7. Matthes H, Herbst H, Schuppan D, et al. Cellular localization of procollagen gene transcripts in inflammatory bowel diseases. Gastroenterology 1992;102:431-42.
8. Becker JM. Surgical therapy for ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1999;28:371-ix.
9. Beltinger J, McKaig BC, Makh S, et al. Human colonic subepithelial myofibroblasts modulate transepithelial resistance and secretory response. Am J Physiol 1999;277(2 Pt 1):C271-C279.
10. Narine K, DeWever O, Cathenis K, et al. Transforming growth factor-beta-induced transition of fibroblasts: a model for myofibroblast procurement in tissue valve engineering. J Heart Valve Dis 2004;13:281-9.
11. Leeb SN, Vogl D, Falk W, et al. Regulation of migration of human colonic myofibroblasts. Growth Factors 2002;20:81-91.
12. Leeb SN, Vogl D, Grossmann J, et al. Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol 2004;99:335-40.
13. Spotti T, Hausmann M, Kreutz M, et al. Monocyte differentiation in intestine-like macrophage phenotype induced by epithelial cells. J Leukoc Biol 2001;70:241-51.
14. Wu KC, Jackson LM, Galvin AM, et al. Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells. Gut 1999;44:323-30.
15. Wallace TD, Bradley S, Buckley ND, et al. Interactions of lactic acid bacteria with human intestinal epithelial cells: effects on cytokine production. J Food Prot 2003;66:466-72.
16. Eckmann L, Jung HC, Schurer-Maly C, et al. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8. Gastroenterology 1993;105:1689-97.
17. Garat C, Arend WP. Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways. Cytokine 2003;23:31-40.
18. Daig R, Rogler G, Aschenbrenner E, et al. Human intestinal epithelial cells secrete interleukin-1 receptor antagonist and interleukin-8 but not interleukin-1 or interleukin-6. Gut 2000;46:350-8.
19. Goke M, Kanai M, Podolsky DK. Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol 1998;274(5 Pt 1):G809-G18.
20. Perdue MH, McKay DM. Integrative immunophysiology in the intestinal mucosa. Am J Physiol 1994;267(2 Pt 1):G151-G65.
21. Halttunen T, Marttinen A, Rantala I, et al. Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology 1996;111:1252-62.
22. Rogler G, Daig R, Aschenbrenner E, et al. Establishment of long-term primary cultures of human small and large intestinal epithelial cells. Lab Invest 1998;78:889-90.
23. Vallance BA, Gunawan MI, Hewlett B, et al. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Am J Physiol Gastrointest Liver Physiol 2005;289:G116-G28.
24. Monteleone G, Mann J, Monteleone I, et al. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation. J Biol Chem 2004;279:3925-32.
25. Neurath MF, Becker C, Barbulescu K. Role of NF-kappaB in immune and inflammatory responses in the gut. Gut 1998;43:856-60.
26. Gelbmann CM, Leeb SN, Vogl D, et al. Inducible CD40 expression mediates NFkappaB activation and cytokine secretion in human colonic fibroblasts. Gut 2003;52:1448-56.
27. Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-kappaB pathway. J Clin Invest 2001;107:143-51.
28. Mellits KH, Mullen J, Wand M, et al. Activation of the transcription factor NF-kappaB by Campylobacter jejuni. Microbiology 2002;148(Pt 9):2753-63.
29. Seetharaman J, Kanigsberg A, Slaaby R, et al. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem 1998;273:13047-52.
30. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002;1572:263-73.
31. Joo HG, Goedegebuure PS, Sadanaga N, et al. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol 2001;69:555-64.
32. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 1996;93:6737-42.
33. Yoshii T, Fukumori T, Honjo Y, et al. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J Biol Chem 2002;277:6852-7.
34. Matarrese P, Tinari N, Semeraro ML, et al. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett 2000;473:311-15.
35. Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci USA 1995;92:1213-7.
36. Cao Z, Said N, Amin S, et al. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J Biol Chem 2002;277:42299-305.
37. Hsu DK, Yang RY, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 2000;156:1073-83.
38. Dumic J, Lauc G, Flogel M. Expression of galectin-3 in cells exposed to stress-roles of jun and NF-kappaB. Cell Physiol Biochem 2000;10:149-58.
39. Sano H, Hsu DK, Yu L, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol 2000;165:2156-64.
40. Cowles EA, Agrwal N, Anderson RL, et al. Carbohydrate-binding protein 35. Isoelectric points of the polypeptide and a phosphorylated derivative. J Biol Chem 1990;265:17706-12.
41. Davidson PJ, Davis MJ, Patterson RJ, et al. Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology 2002;12:329-37.
42. Kim K, Mayer EP, Nachtigal M. Galectin-3 expression in macrophages is signaled by Ras/MAP kinase pathway and up-regulated by modified lipoproteins. Biochim Biophys Acta 2003;1641:13-23.
43. Mehul B, Hughes RC. Plasma membrane forgetting, vesicular budding and release of galectin 3 from the cytoplasm of mammalian cells during secretion. J Cell Sci 1997;110(Pt 10):1169-78.
44. Kasper M, Hughes RC. Immunocytochemical evidence for a modulation of galectin 3 (Mac-2), a carbohydrate binding protein, in pulmonary fibrosis. J Pathol 1996;179:309-16.
45. Jensen-Jarolim E, Neumann C, Oberhuber G, et al. Anti-galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J Clin Immunol 2001;21:348-56.
46. Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, et al. The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol 2002;14:145-52.